Patrick Soon-Shiong
South African and American doctor
Follow Patrick Soon-Shiong on Notably News to receive short updates to your email — rarely!
| January 2025 | Soon-Shiong met with Cheryl Hines and Rob Schneider to discuss creating a conservative talk show modeled after The View. |
| December 2024 | Announced an AI-powered bias meter for the Los Angeles Times coverage, triggering staff resignations and subscription cancellations. |
| November 2024 | Fired the entire editorial board of the Los Angeles Times and announced plans to replace them. |
| October 2024 | Blocked the Los Angeles Times from endorsing Kamala Harris in the presidential election, leading to several editorial board resignations. |
| July 2024 | Sold the San Diego Union-Tribune to MediaNews Group. |
| July 2023 | Sold the San Diego Union-Tribune to MediaNews Group. |
| February 2022 | Invested in Sienza, a lithium battery company in Pasadena, California. |
| January 2022 | Opened a new manufacturing facility and campus in Cape Town, South Africa, with an investment of approximately $250 million. |
| 2021 | Merged NantKwest with ImmunityBio, creating a new publicly traded entity. |
| 2019 | Became an investor in Directa Plus, a European graphene-based technology company, owning 28 percent. |
| September 2018 | NantEnergy announced the development of a zinc-air battery with a projected cost of $100 per kilowatt-hour. |
| June 2018 | Acquires ownership and becomes executive chairman of the Los Angeles Times. |
| June 18 2018 | Closed the sale of the Los Angeles Times and The San Diego Union-Tribune. |
| January 2017 | Soon-Shiong continued meeting privately with Donald Trump during his presidential transition, seeking an administrative position. |
| 2016 | Patrick Soon-Shiong and his family were major donors to Hillary Clinton's presidential campaign. |
| December 2016 | Soon-Shiong met privately with Donald Trump during his presidential transition, attempting to secure a position in the administration. |
| 2015 | NantPharma purchased the drug Cynviloq from Sorrento Therapeutics for $90 million. |
| July 2015 | Initiated an IPO for NantKwest, representing the highest value biotech IPO in history, with a market value of $2.6 billion. |
| January 2013 | Became an early investor in Zoom, the video conferencing company. |
| January 2013 | Founded NantOmics, a biotech company to develop cancer drugs based on protein kinase inhibitors. |
| September 2011 | Founded NantWorks, a technology company with a mission to converge various technological innovations. |
| 2010 | Sold Abraxis to Celgene in a cash-and-stock deal valued at $2.9 billion, earning Soon-Shiong about $533 million in profits. |
| 2010 | Becomes a minority owner of the Los Angeles Lakers professional basketball team. |
This contents of the box above is based on material from the Wikipedia article Patrick Soon-Shiong, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.